Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agilon Health (AGL) Cash from Investing Activities (2020 - 2025)

Historic Cash from Investing Activities for Agilon Health (AGL) over the last 6 years, with Q3 2025 value amounting to $18.7 million.

  • Agilon Health's Cash from Investing Activities fell 5992.96% to $18.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $89.7 million, marking a year-over-year decrease of 2132.61%. This contributed to the annual value of $139.9 million for FY2024, which is 41779.69% up from last year.
  • Per Agilon Health's latest filing, its Cash from Investing Activities stood at $18.7 million for Q3 2025, which was down 5992.96% from $70.5 million recorded in Q2 2025.
  • In the past 5 years, Agilon Health's Cash from Investing Activities ranged from a high of $70.5 million in Q2 2025 and a low of -$296.6 million during Q2 2022
  • Its 5-year average for Cash from Investing Activities is -$19.6 million, with a median of -$8.0 million in 2022.
  • As far as peak fluctuations go, Agilon Health's Cash from Investing Activities tumbled by 294451.41% in 2021, and later skyrocketed by 117458.01% in 2024.
  • Quarter analysis of 5 years shows Agilon Health's Cash from Investing Activities stood at -$2.6 million in 2021, then tumbled by 206.19% to -$8.0 million in 2022, then skyrocketed by 72.36% to -$2.2 million in 2023, then soared by 1174.58% to $23.7 million in 2024, then fell by 21.18% to $18.7 million in 2025.
  • Its last three reported values are $18.7 million in Q3 2025, $70.5 million for Q2 2025, and -$23.1 million during Q1 2025.